Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Kanda

Showing results (91-100 of 422) with videos related to

Pageof 43
Sort By:
Cytotherapy|February 28, 2026
Low reticulocyte count at infusion is a risk factor for ICANS in CAR-T cell therapyYusuke Tashiro, Tomoyasu Jo, Toshio Kitawaki, et al.
British Journal of Haematology|February 26, 2025
Acute myeloid leukaemia with SRSF2 and BRAF mutations preceded by histiocytic proliferation in the bone marrowMinako Mori, Tomomi Sakai, Tomomi Oka, et al.
International Journal of Hematology|January 14, 2023
Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndromeAsami Kataoka, Chisaki Mizumoto, Junya Kanda, et al.
International Journal of Hematology|February 21, 2023
An adult case of refractory autoimmune neutropenia after liver transplantationHuye Sun, Fumiya Wada, Junya Kanda, et al.
International Journal of Hematology|March 10, 2023
Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutationsKazunori Toratani, Mizuki Watanabe, Junya Kanda, et al.
Transfusion|May 29, 2026
Usefulness of pegfilgrastim for allogeneic peripheral blood stem cell collection from healthy donorsTomoshige Shimizu, Tomoyasu Jo, Noriyoshi Yoshinaga, et al.
International Journal of Hematology|June 25, 2026
Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapyYusuke Tashiro, Tomoyasu Jo, Toshio Kitawaki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2016
Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous HaplotypesJunya Kanda, Kazuhiro Ikegame, Shigeo Fuji, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 23, 2022
Evaluation of indices for predicting recovery of exercise tolerance in patients surviving allogenic hematopoietic stem cell transplantationRyota Hamada, Tadakazu Kondo, Kazuhiro Harada, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|November 29, 2025
Association of serum myokine levels with rapid degeneration in skeletal muscle quality following allogeneic hematopoietic stem cell transplantationMasanobu Murao, Ryota Hamada, Junya Kanda, et al.
Pageof 43

Showing results (91-100 of 422) with videos related to

Sort By:
Pageof 43
Cytotherapy|February 28, 2026
Low reticulocyte count at infusion is a risk factor for ICANS in CAR-T cell therapyYusuke Tashiro, Tomoyasu Jo, Toshio Kitawaki, et al.
British Journal of Haematology|February 26, 2025
Acute myeloid leukaemia with SRSF2 and BRAF mutations preceded by histiocytic proliferation in the bone marrowMinako Mori, Tomomi Sakai, Tomomi Oka, et al.
International Journal of Hematology|January 14, 2023
Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndromeAsami Kataoka, Chisaki Mizumoto, Junya Kanda, et al.
International Journal of Hematology|February 21, 2023
An adult case of refractory autoimmune neutropenia after liver transplantationHuye Sun, Fumiya Wada, Junya Kanda, et al.
International Journal of Hematology|March 10, 2023
Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutationsKazunori Toratani, Mizuki Watanabe, Junya Kanda, et al.
Transfusion|May 29, 2026
Usefulness of pegfilgrastim for allogeneic peripheral blood stem cell collection from healthy donorsTomoshige Shimizu, Tomoyasu Jo, Noriyoshi Yoshinaga, et al.
International Journal of Hematology|June 25, 2026
Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapyYusuke Tashiro, Tomoyasu Jo, Toshio Kitawaki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2016
Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous HaplotypesJunya Kanda, Kazuhiro Ikegame, Shigeo Fuji, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 23, 2022
Evaluation of indices for predicting recovery of exercise tolerance in patients surviving allogenic hematopoietic stem cell transplantationRyota Hamada, Tadakazu Kondo, Kazuhiro Harada, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|November 29, 2025
Association of serum myokine levels with rapid degeneration in skeletal muscle quality following allogeneic hematopoietic stem cell transplantationMasanobu Murao, Ryota Hamada, Junya Kanda, et al.
Pageof 43